Alabama Hospice Care Of Tuscaloosa 3064 Palisades Court, Tuscaloosa, AL, 35405 | |
(205) 383-3356 |
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
Name | Alabama Hospice Care Of Tuscaloosa |
---|---|
Location | 3064 Palisades Court, Tuscaloosa, Alabama |
Hospice ID | 011677 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 620 |
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
NPI Number | 1518269885 |
Organization Name | Lhcg Xxii, Llc |
Address | 3064 Palisades Ct Tuscaloosa, Alabama, 35405 |
Phone Number | (205)633-3705 |
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
NPI Number | 1669663472 |
Organization Name | Hospice Complete, Inc |
Address | 3064 Palisades Ct Tuscaloosa, Alabama, 35405 |
Phone Number | (205)633-3705 |
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 98.6 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.6 | 93.3 |
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
Home Health Aides | 4 |
Counselors | 0.5 |
Medical Social Workers | 1.25 |
Physicians | 1 |
Registered Nurses | 6 |
Other Personnel | 4 |
Total Employees | 16.75 |
---|
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
Others | 3 |
Total Volunteers | 3 |
---|
News Archive
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable-but certain experiences create opportunities for parts of the adult brain to rewire and learn again.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
› Verified 4 days ago
Hospice Of West Alabama Location: 3851 Loop Road, Tuscaloosa, Alabama, 35404 Phone: (205) 383-3356 |
Journey Hospice Of Alabama Location: 4128 Crosshaven Drive, Tuscaloosa, Alabama, 35406 Phone: (205) 383-3356 |
Alabama Hospice Care Of Tuscaloosa Location: 3064 Palisades Court, Tuscaloosa, Alabama, 35405 Phone: (205) 383-3356 |